Simple Advice For A Healthier Lifestyle To Help Prevent A Stroke
By News on the Net Tuesday, April 24, 2012
Houston, TX, – Forty-hour work weeks, two-hour commutes, carpools, school conferences, commitments: who has time to eat healthy foods and exercise? And who can afford pricey organic, fresh foods anyway? You can, according to Randy Wright, MD and his co-author David Tabatsky. They spell it out in practical terms in The Wright Choice: Your Family’s Prescription for Healthy Eating, Modern Fitness and Saving Money (Intouch Media Health Network).
New treatment for prostate cancer gives ‘perfect results’ for nine in ten men: researchBy News on the Net Monday, April 16, 2012
Handheld device for doing blood tests moves closer to medical use
By American Chemical Society Wednesday, April 11, 2012
Analytical Chemistry
Scientists are reporting a key advance in efforts to develop a handheld device that could revolutionize the complete blood cell count (CBC), one of the most frequently performed blood tests used to diagnose and treat disease. In a report in ACS’ journal Analytical Chemistry, they describe adding a key feature to their “blood lab-on-a-chip” that allows it to count white blood cells more accurately.
Medizone International Announces Successful Production of AsepticSure Hospital Disinfection SystemBy News on the Net Tuesday, April 10, 2012
San Francisco, CA - Medizone International, Inc. (MZEI:OB) (MZEI:QB) announced today that the first production unit of its HYPERLINK “http://medizoneint.com/asepticsure/dr-dick-zoutman-presents-the-case-for-asepticsure/“AsepticSure disinfection technology has been successfully completed by its manufacturing partner, SMTC Corporation (NASDAQ:SMTX).
Advance toward an imaging agent for diagnosing Alzheimer’s diseaseBy American Chemical Society Wednesday, April 4, 2012
ACS Medicinal Chemistry Letters
Scientists are reporting development and initial laboratory tests of an imaging agent that shows promise for detecting the tell-tale signs of Alzheimer’s disease (AD) in the brain — signs that now can’t confirm a diagnosis until after patients have died. Their report appears in the journal ACS Medicinal Chemistry Letters.
Vaccine to stop heart attacks could be here in 5 years
By News on the Net Friday, March 30, 2012
Merck Contributes $35 million to Merck Lumira Biosciences Fund in Quebec
By News on the Net Tuesday, March 27, 2012
OTTAWA, - Rx&D President Russell Williams made the following statement today about the Merck Lumira Biosciences Fund, which will fuel future pharmaceutical innovation in Quebec.
Why coffee drinking reduces the risk of Type 2 diabetesBy American Chemical Society Wednesday, March 14, 2012
Journal of Agricultural & Food Chemistry
Why do heavy coffee drinkers have a lower risk of developing Type 2 diabetes, a disease on the increase around the world that can lead to serious health problems? Scientists are offering a new solution to that long-standing mystery in a report in ACS’ Journal of Agricultural & Food Chemistry.
Cuddling dying pets gives owners scary infectionsBy News on the Net Friday, March 2, 2012
CDC Issues Warning About Nasal Washes
By News on the Net Thursday, March 1, 2012
DENVER (CBS4) – The Centers for Disease Control and Prevention and National Jewish Health in Colorado both have issued a warning about nasal washes after two people have died from using tap water to do their sinus rinse.
Adapting personal glucose monitors to detect DNA
By American Chemical Society Wednesday, February 29, 2012
Analytical Chemistry
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study. The report on this adaptation of the ubiquitous personal glucose monitor, typically used to test blood sugar levels, appears in ACS’ journal Analytical Chemistry.
Statement - GlaxoSmithKline invests $12 Million in Canada for Influenza ResearchBy Guest Column Thursday, February 23, 2012
OTTAWA, - Rx&D President Russell Williams made the following statement today about GlaxoSmithKline plc’s new funding of $12 Million to support an additional three-years of research to monitor seasonal influenza vaccine effectiveness in the elderly.
Health Canada approves extended use of Prevnar® 13 in adults 50 years and olderBy Guest Column Wednesday, February 15, 2012
KIRKLAND, QC, - Pfizer Canada Inc. is pleased to announce Health Canada’s approval of the extended use of Prevnar® 13 for active immunization for the prevention of invasive pneumococcal disease (IPD) (including sepsis, meningitis, bacteraemic pneumonia, pleural empyema and bacteraemia) in adults 50 years of age and older caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.1 Prevnar® 13 is a conjugate vaccine made from the purified polysaccharides of 13 different serotypes of S. pneumoniae individually conjugated to non-toxic diphtheria cross reactive material 197 (CRM197) protein. Prevnar® 13 was first approved in December 2009 for use in children and infants from 6 weeks through 5 years of age for the active immunization against IPD caused by the serotypes of S. pneumoniae contained in the vaccine.
New process could advance use of healthy cells or stem cells to treat diseaseBy American Chemical Society Wednesday, February 8, 2012
Langmuir
In a discovery that may help speed use of “cell therapy” — with normal cells or stem cells infused into the body to treat disease — scientists are reporting development of a way to deliver therapeutic human cells to diseased areas within the body using a simple magnetic effect. Their report appears in ACS’ journal Langmuir.
Arsenic criticality poses concern for modern technologyBy American Chemical Society Wednesday, February 8, 2012
Environmental Science & Technology
Risks related to the critical nature of arsenic — used to make high-speed computer chips that contain gallium arsenide — outstrip those of other substances in a group of critical materials needed to sustain modern technology, a new study has found. Scientists evaluated the relative criticality of arsenic and five related metals in a report in the ACS’ journal Environmental Science & Technology.
Next 15 Columns
